IP Library Granted Patent US 6,846,922
Granted Patent B1
US 6,846,922 · App. 09/708,224 · Granted Jan 25, 2005

Activators for oligonucleotide synthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,846,922
App. No.
09/708,224
Granted
Jan 25, 2005
Kind
B1
Abstract

The present invention relates to improved methods for the preparation of nucleoside phosphoramidites and oligonucleotides. In one aspect, the methods of the invention are used to prepare phosphitylating reagents using pyridinium salts as activators. In a further aspect, the methods of the invention are used to prepare internucleoside linkages using activators which include at least one pyridinium salt and at least one substituted imidazole. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having 2′-substituents using imidazolium or benzimidazolium salts as an activator. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having bioreversible protecting group that confers enhanced chemical and biophysical properties, without exocyclic amine protection, using imidazolium or benzimidazolium salts as an activator.

Claims (16)

1. A method for the preparation of a compound of formula:

wherein:

R 1 is a nucleoside or an oligonucleotide;

R 2 is a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;

Pg is a phosphorus protecting group; comprising:

providing a phosphoramidite of formula:

 wherein

R 6 is —N(R 7 ) 2 wherein R 7 is alkyl having from one to about six carbons; or R 7 is a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms, and having up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen; and

reacting said phosphoramidite with a hydroxyl group of a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;

said reaction being performed in the presence of an activating reagent, said activating reagent comprising at least one pyridinium salt and at least one substituted imidazole.

2. The method of claim 1 wherein said pyridinium salt has the formula

where X − is trifluoroacetate, − O-mesyl, − O-tosyl, − Br, − O-trifluorosulfonyl, hexafluorophosphate or tetrafluoroborate.

3. The method of claim 2 wherein the substituted imidazole is 1-methylimidazole.

4. The method of claim 2 wherein X is trifluoroacetate.

5. The method of claim 1 wherein the phosphoramidite is reacted with the 5′-hydroxyl of a solid-support bound nucleoside or oligonucleotide.

6. The method of claim 1 wherein the oligonucleotide comprises phosphorothioate intersugar linkages.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2001
From: MANOHARAN, MUTHIAH; RAVIKUMAR, VASULINGA T.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 012112/0209 →